Aspergillus is a genus of filamentous fungi that encompasses a diverse group of molds commonly found in the environment. With over 200 known species, Aspergillus plays a significant role in decomposing organic matter and contributing to nutrient cycling. However, some species within this genus can pose health risks, particularly for immunocompromised individuals. Aspergillus fumigatus is the most clinically relevant species, causing a range of respiratory infections, including allergic bronchopulmonary aspergillosis (ABPA), invasive aspergillosis, and chronic pulmonary aspergillosis. Infections by Aspergillus species are often associated with individuals with weakened immune systems, such as those undergoing chemotherapy or organ transplantation. Inhalation of Aspergillus spores can lead to colonization of the respiratory tract, with invasive disease occurring in severe cases. Allergic reactions to Aspergillus antigens can also result in hypersensitivity lung diseases. Diagnosing Aspergillus infections requires a combination of clinical evaluation, imaging studies, and laboratory tests, including cultures and molecular techniques. Antifungal medications, such as voriconazole, are commonly used for treatment.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Climate change & increasing pollution and respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Climate change & increasing tickborne illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Invasive group A streptococcal infections in children: Current therapeutic challenges
Elena Chiappini, University of Florence, Italy
Title : Trends of treatment and vaccines for influenza, COVID-19, and pneumococcal diseases
Masafumi Seki, Saitama Medical University International Medical Center, Japan